Clinical Trials Directory

Trials / Unknown

UnknownNCT04637373

Hysteroscopy Assisted Suction Curettage for Early Pregnancy Loss

Hysteroscopy Assisted Suction Curettage for Early Pregnancy Loss: Does it Reduce Retained Products of Conception and Postoperative Intrauterine Adhesions?

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Assaf-Harofeh Medical Center · Other Government
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

Retained products of conception (RPOC) and intrauterine adhesions (IUA) may occur following suction curettage for early miscarriage and cause secondary infertility, recurrent pregnancy loss and pregnancy complications. The aim of this study is to investigate whether adding hysteroscopy to suction curettage reduces the rates of RPOC and IUA.

Detailed description

This is a descriptive, prospective study. Women aged 18-40 years admitted for surgical evacuation in cases of early missed abortion in a single university affiliated medical center are being recruited. All procedures performed under general anesthesia following cervical ripening with vaginal Misoprostol. Before the evacuation, a diagnostic hysteroscopy was performed to identify the pregnancy's implantation wall. Subsequently, ultrasound guided suction and curettage directed to the implantation wall is done. Finally, the uterine cavity is evaluated by hysteroscopy for RPOC. Participants are scheduled for follow-up diagnostic office hysteroscopy 2 months after termination of pregnancy for assessment of IUA and RPOC. However, due to restrictions on elective surgical procedures brought on by the Covid-19 pandemic, the follow-up hysteroscopy examination was postponed until 5 to 6 months after termination of pregnancy.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTHysteroscopyadding Hysteroscopy before and after suction curettage for early missed abortion to define the wall of implantation and look for retained products of conception

Timeline

Start date
2019-07-01
Primary completion
2020-11-04
Completion
2020-12-31
First posted
2020-11-19
Last updated
2020-11-19

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT04637373. Inclusion in this directory is not an endorsement.